The risk or severity of adverse effects can be increased when Nepafenac is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when ramipril is combined with D-mannitol.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when amoxapine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when halcinonide is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when ramipril is combined with etodolac.


The risk or severity of adverse effects can be increased when nimodipine is combined with clonidine.


The risk or severity of adverse effects can be increased when ketoconazole is combined with oxycodone.


The risk or severity of adverse effects can be increased when barnidipine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when methysergide is combined with Conivaptan.


The risk or severity of adverse effects can be increased when amitriptyline is combined with tiagabine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with sulpiride.


The risk or severity of adverse effects can be increased when Bortezomib is combined with epoprostenol.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with carisoprodol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Bortezomib is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when citalopram is combined with Perospirone.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when amisulpride is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when amitriptyline is combined with zonisamide.


The risk or severity of adverse effects can be increased when ketoprofen is combined with equilin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when estazolam is combined with tizanidine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with PAMABROM.


The risk or severity of adverse effects can be increased when nalbuphine is combined with zaleplon.


The risk or severity of adverse effects can be increased when dyclonine is combined with phenytoin.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Articaine.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with cinoxacin.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with metoclopramide.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with flumethasone.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with enflurane.


The risk or severity of adverse effects can be increased when meprobamate is combined with clorazepate.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when buspirone is combined with thiothixene.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Conivaptan.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Eprosartan.


The risk or severity of adverse effects can be increased when buspirone is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Melatonin.


The risk or severity of adverse effects can be increased when Posaconazole is combined with Vinflunine.


The risk or severity of adverse effects can be increased when apomorphine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with tetracaine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with promethazine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with clonazepam.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with nifedipine.


The risk or severity of adverse effects can be increased when halothane is combined with ethotoin.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when glipizide is combined with ethanol.


The risk or severity of adverse effects can be increased when formestane is combined with metoclopramide.


The risk or severity of adverse effects can be increased when Ramelteon is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Pipamperone.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Rotigotine.


The risk or severity of adverse effects can be increased when propofol is combined with Pizotifen.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with ethosuximide.


The risk or severity of adverse effects can be increased when meprobamate is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when gabapentin is combined with thiamylal.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with thiopental.


The risk or severity of adverse effects can be increased when Limaprost is combined with Ditazole.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Nebivolol.


The risk or severity of adverse effects can be increased when Alogliptin is combined with enalapril.


The risk or severity of adverse effects can be increased when nalbuphine is combined with triamterene.


The risk or severity of adverse effects can be increased when meperidine is combined with sulpiride.


The risk or severity of adverse effects can be increased when estazolam is combined with dyclonine.


The risk or severity of adverse effects can be increased when meperidine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with cetirizine.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with mecamylamine.


The risk or severity of adverse effects can be increased when estazolam is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with DESONIDE.


The risk or severity of adverse effects can be increased when estazolam is combined with fludiazepam.


The risk or severity of adverse effects can be increased when cabergoline is combined with miconazole.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when clomipramine is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with doxazosin.


The risk or severity of adverse effects can be increased when alprazolam is combined with Paliperidone.


The risk or severity of adverse effects can be increased when betaxolol is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with niflumic acid.


The risk or severity of adverse effects can be increased when perphenazine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with fenoprofen.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Escitalopram.


The risk or severity of adverse effects can be increased when nalbuphine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when oxazepam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Nepafenac is combined with budesonide.


The risk or severity of adverse effects can be increased when dibucaine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when terbinafine is combined with Amrinone.


The risk or severity of adverse effects can be increased when diclofenac is combined with medrysone.


The risk or severity of adverse effects can be increased when tenoxicam is combined with azelastine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with chlormezanone.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when perphenazine is combined with glutethimide.


The risk or severity of adverse effects can be increased when midazolam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when clorazepate is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Rufinamide is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when nortriptyline is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when pentobarbital is combined with pentazocine.


The risk or severity of adverse effects can be increased when lorazepam is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Levomepromazine.


The risk or severity of adverse effects can be increased when celecoxib is combined with Mometasone.


The risk or severity of adverse effects can be increased when suprofen is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Efonidipine is combined with triamterene.


The risk or severity of adverse effects can be increased when suprofen is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when meperidine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when doxepin is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when thiopental is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when thiopental is combined with glutethimide.


The risk or severity of adverse effects can be increased when clorazepate is combined with Pipamperone.


The risk or severity of adverse effects can be increased when nitrendipine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Perospirone.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when sumatriptan is combined with loxapine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Remoxipride.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when nabumetone is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when rescinnamine is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when Tramadol is combined with Olopatadine.


The risk or severity of adverse effects can be increased when difluprednate is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when proparacaine is combined with Normethadone.


The risk or severity of adverse effects can be increased when floctafenine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when pramipexole is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when baclofen is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when benzocaine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when oxybutynin is combined with Propiverine.


The risk or severity of adverse effects can be increased when midazolam is combined with brotizolam.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when loxapine is combined with loratadine.


The risk or severity of adverse effects can be increased when methysergide is combined with GLYCEROL PHENYLBUTYRATE.


The risk or severity of adverse effects can be increased when Butethal is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when equilin is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when Artemether is combined with Clevidipine.


The risk or severity of adverse effects can be increased when clozapine is combined with Flupentixol.


The risk or severity of adverse effects can be increased when clozapine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when tolmetin is combined with azelastine.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with etodolac.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with quetiapine.


The risk or severity of adverse effects can be increased when isoflurane is combined with dantrolene.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with Eprosartan.


The risk or severity of adverse effects can be increased when butamben is combined with cetirizine.


The risk or severity of adverse effects can be increased when morphine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when butamben is combined with protriptyline.


The risk or severity of adverse effects can be increased when D-mannitol is combined with quinapril.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with buprenorphine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with alclofenac.


The risk or severity of adverse effects can be increased when antipyrine is combined with acemetacin.


The risk or severity of adverse effects can be increased when selegiline is combined with hydromorphone.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with oxymorphone.


The risk or severity of adverse effects can be increased when pentazocine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when enalapril is combined with Naftifine.


The risk or severity of adverse effects can be increased when butabarbital is combined with sevoflurane.


The risk or severity of adverse effects can be increased when furazolidone is combined with maprotiline.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with fosinopril.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when Escitalopram is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with Normethadone.


The risk or severity of adverse effects can be increased when butabarbital is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when minoxidil is combined with Eprosartan.


The risk or severity of adverse effects can be increased when temazepam is combined with doxepin.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with formestane.


The risk or severity of adverse effects can be increased when nicardipine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Imatinib is combined with atorvastatin.


The risk or severity of adverse effects can be increased when loxapine is combined with amoxapine.


The risk or severity of adverse effects can be increased when Halazepam is combined with phenytoin.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when Suvorexant is combined with Escitalopram.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when clorazepate is combined with clozapine.


The risk or severity of adverse effects can be increased when thioridazine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when benazepril is combined with furosemide.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when olanzapine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when aspirin is combined with alclofenac.


The risk or severity of adverse effects can be increased when Clofarabine is combined with metoprolol.


The risk or severity of adverse effects can be increased when Clofarabine is combined with ropinirole.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when cabergoline is combined with meperidine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with flumethasone.


The risk or severity of adverse effects can be increased when butamben is combined with Desloratadine.


The risk or severity of adverse effects can be increased when thioridazine is combined with nitrazepam.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with ethotoin.


The risk or severity of adverse effects can be increased when ketoprofen is combined with alclometasone.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when protriptyline is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Perospirone.


The risk or severity of adverse effects can be increased when nicergoline is combined with Zucapsaicin.


The risk or severity of adverse effects can be increased when protriptyline is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with quinapril.


The risk or severity of adverse effects can be increased when thioridazine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when thioridazine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when thioridazine is combined with spironolactone.


The risk or severity of adverse effects can be increased when benazepril is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when benazepril is combined with methyldopa.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with quetiapine.


The risk or severity of adverse effects can be increased when trazodone is combined with etizolam.


The risk or severity of adverse effects can be increased when tetracaine is combined with primidone.


The risk or severity of adverse effects can be increased when flunarizine is combined with pravastatin.


The risk or severity of adverse effects can be increased when zopiclone is combined with topiramate.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when pimozide is combined with ondansetron.


The risk or severity of adverse effects can be increased when Asenapine is combined with butamben.


The risk or severity of adverse effects can be increased when pimozide is combined with tiagabine.


The risk or severity of adverse effects can be increased when terbinafine is combined with nimesulide.


The risk or severity of adverse effects can be increased when pimozide is combined with zonisamide.


The risk or severity of adverse effects can be increased when Telmisartan is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with donepezil.


The risk or severity of adverse effects can be increased when butabarbital is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with tiagabine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with cocaine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with ondansetron.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with felbamate.


The risk or severity of adverse effects can be increased when Flupentixol is combined with zonisamide.


The risk or severity of adverse effects can be increased when promazine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when proparacaine is combined with benzocaine.


The risk or severity of adverse effects can be increased when promazine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when promazine is combined with zotepine.


The risk or severity of adverse effects can be increased when chloroxine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when sulpiride is combined with desipramine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with flunarizine.


The risk or severity of adverse effects can be increased when sulpiride is combined with halothane.


The risk or severity of adverse effects can be increased when resveratrol is combined with fluocinonide.


The risk or severity of adverse effects can be increased when selegiline is combined with doxepin.


The risk or severity of adverse effects can be increased when trichlormethiazide is combined with carbamazepine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with maprotiline.


The risk or severity of adverse effects can be increased when Remoxipride is combined with mesoridazine.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when carprofen is combined with Icatibant.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with daunorubicin.


The risk or severity of adverse effects can be increased when alclofenac is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when Fospropofol is combined with amoxapine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when secobarbital is combined with prilocaine.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Olopatadine is combined with flunisolide.


The risk or severity of adverse effects can be increased when rapamycin is combined with nimesulide.


The risk or severity of adverse effects can be increased when gabapentin is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when meprobamate is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when pimozide is combined with meclizine.


The risk or severity of adverse effects can be increased when diazepam is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when reserpine is combined with protriptyline.


The risk or severity of adverse effects can be increased when diazepam is combined with Remoxipride.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when reserpine is combined with cetirizine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when methylergonovine is combined with doxycycline.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when paramethasone is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when amifostine is combined with triamterene.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when protriptyline is combined with Bambuterol.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when diflunisal is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with zaleplon.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with mepivacaine.


The risk or severity of adverse effects can be increased when nisoldipine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when thiamylal is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when indomethacin is combined with resveratrol.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with hydralazine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with imipramine.


The risk or severity of adverse effects can be increased when Pirlindole is combined with metaproterenol.


The risk or severity of adverse effects can be increased when Droxicam is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when Droxicam is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with citalopram.


The risk or severity of adverse effects can be increased when promazine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when amiodarone is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when tiapride is combined with felbamate.


The risk or severity of adverse effects can be increased when nitric oxide is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when isradipine is combined with diltiazem.


The risk or severity of adverse effects can be increased when Torasemide is combined with daunorubicin.


The risk or severity of adverse effects can be increased when Treprostinil is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when levorphanol is combined with methocarbamol.


The risk or severity of adverse effects can be increased when levorphanol is combined with spironolactone.


The risk or severity of adverse effects can be increased when levorphanol is combined with triprolidine.


The risk or severity of adverse effects can be increased when Pentolinium is combined with topiramate.


The risk or severity of adverse effects can be increased when alprazolam is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with clomipramine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when budesonide is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when Spirapril is combined with fenbufen.


The risk or severity of adverse effects can be increased when haloperidol is combined with clorazepate.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Torasemide.


The risk or severity of adverse effects can be increased when loratadine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with zotepine.


The risk or severity of adverse effects can be increased when estramustine is combined with leflunomide.


The risk or severity of adverse effects can be increased when Arotinolol is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when Arotinolol is combined with tolazoline.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Pipamperone.


The risk or severity of adverse effects can be increased when alprazolam is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when efavirenz is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Pipamperone is combined with terazosin.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when midazolam is combined with amobarbital.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with xylometazoline.


The risk or severity of adverse effects can be increased when midazolam is combined with Butethal.


The risk or severity of adverse effects can be increased when fosinopril is combined with penbutolol.


The risk or severity of adverse effects can be increased when methylphenidate is combined with ropinirole.


The risk or severity of adverse effects can be increased when Tasimelteon is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with indapamide.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when tropicamide is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with procaine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with trimipramine.


The risk or severity of adverse effects can be increased when resveratrol is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when meprobamate is combined with perphenazine.


The risk or severity of adverse effects can be increased when meprobamate is combined with levorphanol.


The risk or severity of adverse effects can be increased when niflumic acid is combined with medrysone.


The risk or severity of adverse effects can be increased when clorazepate is combined with risperidone.


The risk or severity of adverse effects can be increased when clemastine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when clidinium is combined with citalopram.


The risk or severity of adverse effects can be increased when perphenazine is combined with triprolidine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Difenoxin.


The risk or severity of adverse effects can be increased when perphenazine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when perphenazine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with ethotoin.


The risk or severity of adverse effects can be increased when resveratrol is combined with Apremilast.


The risk or severity of adverse effects can be increased when methysergide is combined with Telaprevir.


The risk or severity of adverse effects can be increased when minoxidil is combined with nisoldipine.


The risk or severity of adverse effects can be increased when levorphanol is combined with clemastine.


The risk or severity of adverse effects can be increased when tacrolimus is combined with CAPECITABINE.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when salicylic acid is combined with rosiglitazone.


The risk or severity of adverse effects can be increased when THYMOL is combined with xylometazoline.


The risk or severity of adverse effects can be increased when methadone is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Melatonin is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Bretylium is combined with Riociguat.


The risk or severity of adverse effects can be increased when tacrolimus is combined with temozolomide.


The risk or severity of adverse effects can be increased when tacrolimus is combined with dacarbazine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with thiopental.


The risk or severity of adverse effects can be increased when promazine is combined with cocaine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with tiapride.


The risk or severity of adverse effects can be increased when fexofenadine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when ramipril is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when naltrexone is combined with Methylnaltrexone.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with doxorubicin.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with oxaprozin.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with azathioprine.


The risk or severity of adverse effects can be increased when fenoldopam is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Treprostinil is combined with Nepafenac.


The risk or severity of adverse effects can be increased when proparacaine is combined with ethotoin.


The risk or severity of adverse effects can be increased when Phenelzine is combined with brimonidine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Etomidate is combined with tetracaine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Flibanserin.


The risk or severity of adverse effects can be increased when pentazocine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when flumethasone is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when hydromorphone is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with butorphanol.


The risk or severity of adverse effects can be increased when Articaine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when ethotoin is combined with tiagabine.


The risk or severity of adverse effects can be increased when triamterene is combined with AMMONIUM CHLORIDE.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with medrysone.


The risk or severity of adverse effects can be increased when morphine is combined with quetiapine.


The risk or severity of adverse effects can be increased when enalapril is combined with Nepafenac.


The risk or severity of adverse effects can be increased when nimodipine is combined with doxazosin.


The risk or severity of adverse effects can be increased when LISURIDE is combined with progesterone.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when isoflurane is combined with Sacubitril.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Sorafenib.


The risk or severity of adverse effects can be increased when proparacaine is combined with clemastine.


The risk or severity of adverse effects can be increased when Metipranolol is combined with Varenicline.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Metipranolol is combined with hydralazine.


The risk or severity of adverse effects can be increased when fosinopril is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when nalbuphine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with triprolidine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with nilvadipine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with methocarbamol.


The risk or severity of adverse effects can be increased when ibuprofen is combined with alclometasone.


The risk or severity of adverse effects can be increased when Benidipine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with manidipine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when butalbital is combined with promethazine.


The risk or severity of adverse effects can be increased when mitoxantrone is combined with leflunomide.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with decamethonium.


The risk or severity of adverse effects can be increased when etizolam is combined with meclizine.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with Lacidipine.


The risk or severity of adverse effects can be increased when nimesulide is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with halcinonide.


The risk or severity of adverse effects can be increased when carisoprodol is combined with ethosuximide.


The risk or severity of adverse effects can be increased when codeine is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with difluprednate.


The risk or severity of adverse effects can be increased when QUINETHAZONE is combined with carbamazepine.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Perospirone.


The risk or severity of adverse effects can be increased when Propacetamol is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when bepridil is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when HEROIN is combined with etizolam.


The risk or severity of adverse effects can be increased when rasagiline is combined with Iloperidone.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with Amrinone.


The risk or severity of adverse effects can be increased when griseofulvin is combined with cinnarizine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with thiothixene.


The risk or severity of adverse effects can be increased when Levocetirizine is combined with sertraline.


The risk or severity of adverse effects can be increased when morphine is combined with valsartan.


The risk or severity of adverse effects can be increased when clorazepate is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when trandolapril is combined with nimesulide.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with carprofen.


The risk or severity of adverse effects can be increased when glutethimide is combined with Difenoxin.


The risk or severity of adverse effects can be increased when ketoconazole is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when lisinopril is combined with Salsalate.


The risk or severity of adverse effects can be increased when cabergoline is combined with caffeine.


The risk or severity of adverse effects can be increased when cabergoline is combined with azithromycin.


The risk or severity of adverse effects can be increased when cabergoline is combined with reserpine.


The risk or severity of adverse effects can be increased when proparacaine is combined with thiamylal.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Iloperidone.


The risk or severity of adverse effects can be increased when ramipril is combined with Nepafenac.


The risk or severity of adverse effects can be increased when proparacaine is combined with desipramine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Perospirone.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when promazine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when tolterodine is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with thiothixene.


The risk or severity of adverse effects can be increased when triflupromazine is combined with imipramine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Pipamperone.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Normethadone.


The risk or severity of adverse effects can be increased when benazepril is combined with fenoprofen.


The risk or severity of adverse effects can be increased when hexetidine is combined with nimodipine.


The risk or severity of adverse effects can be increased when imipramine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when hydromorphone is combined with nalbuphine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with efavirenz.


The risk or severity of adverse effects can be increased when hydromorphone is combined with oxazepam.


The risk or severity of adverse effects can be increased when codeine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Fospropofol is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when paroxetine is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when paroxetine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Normethadone is combined with clomipramine.


The risk or severity of adverse effects can be increased when phentolamine is combined with methazolamide.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with teniposide.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Pramocaine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when protriptyline is combined with nefazodone.


The risk or severity of adverse effects can be increased when dimethyl sulfoxide is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Iloperidone.


The risk or severity of adverse effects can be increased when proparacaine is combined with brotizolam.


The risk or severity of adverse effects can be increased when docetaxel is combined with carmustine.


The risk or severity of adverse effects can be increased when docetaxel is combined with anagrelide.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when codeine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when thiothixene is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Nabilone is combined with lisinopril.


The risk or severity of adverse effects can be increased when procyclidine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with Retigabine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when fenoldopam is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when risperidone is combined with chlormezanone.


The risk or severity of adverse effects can be increased when risperidone is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when benztropine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with dipyridamole.


The risk or severity of adverse effects can be increased when etizolam is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with salicylamide.


The risk or severity of adverse effects can be increased when isradipine is combined with doxazosin.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when diflunisal is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when irbesartan is combined with terazosin.


The risk or severity of adverse effects can be increased when Vilazodone is combined with doxepin.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with medrysone.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when butorphanol is combined with Flupentixol.


The risk or severity of adverse effects can be increased when butorphanol is combined with Conivaptan.


The risk or severity of adverse effects can be increased when procyclidine is combined with tropicamide.


The risk or severity of adverse effects can be increased when clotrimazole is combined with nifedipine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Pramocaine.


The risk or severity of adverse effects can be increased when vigabatrin is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when thiothixene is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when propoxyphene is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when betaxolol is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when oxycodone is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when oxycodone is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Asenapine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when dibucaine is combined with amisulpride.


The risk or severity of adverse effects can be increased when Asenapine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when dibucaine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when secobarbital is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when losartan is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with sulindac.


The risk or severity of adverse effects can be increased when procyclidine is combined with Mirabegron.


The risk or severity of adverse effects can be increased when losartan is combined with Eprosartan.


The risk or severity of adverse effects can be increased when benzocaine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when nimesulide is combined with epirizole.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with chloroquine.


The risk or severity of adverse effects can be increased when nilvadipine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when butorphanol is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with propoxyphene.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with ANISOTROPINE METHYLBROMIDE.


The risk or severity of adverse effects can be increased when cilnidipine is combined with losartan.


The risk or severity of adverse effects can be increased when cilnidipine is combined with thioridazine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when ondansetron is combined with clidinium.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with buprenorphine.


The risk or severity of adverse effects can be increased when Pregabalin is combined with pravastatin.


The risk or severity of adverse effects can be increased when Lacidipine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when D-mannitol is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Conivaptan is combined with rasagiline.


The risk or severity of adverse effects can be increased when losartan is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when meperidine is combined with periciazine.


The risk or severity of adverse effects can be increased when butorphanol is combined with sevoflurane.


The risk or severity of adverse effects can be increased when orphenadrine is combined with duloxetine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with nabumetone.


The risk or severity of adverse effects can be increased when orphenadrine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when benzphetamine is combined with Ephedrine.


The risk or severity of adverse effects can be increased when benzphetamine is combined with MEPHENTERMINE.


The risk or severity of adverse effects can be increased when Olmesartan is combined with tenoxicam.


The risk or severity of adverse effects can be increased when fludiazepam is combined with tiagabine.


The risk or severity of adverse effects can be increased when baclofen is combined with butalbital.


The risk or severity of adverse effects can be increased when triprolidine is combined with paroxetine.


The risk or severity of adverse effects can be increased when enflurane is combined with mesoridazine.


The risk or severity of adverse effects can be increased when aspirin is combined with budesonide.


The risk or severity of adverse effects can be increased when halothane is combined with fexofenadine.


The risk or severity of adverse effects can be increased when enflurane is combined with maprotiline.


The risk or severity of adverse effects can be increased when diltiazem is combined with doxazosin.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Flibanserin.


The risk or severity of adverse effects can be increased when diltiazem is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when indomethacin is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when diltiazem is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when dicyclomine is combined with oxybutynin.


The risk or severity of adverse effects can be increased when cytarabine is combined with leflunomide.


The risk or severity of adverse effects can be increased when acemetacin is combined with diflorasone.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when secobarbital is combined with quetiapine.


The risk or severity of adverse effects can be increased when lidocaine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with oxaliplatin.


The risk or severity of adverse effects can be increased when Metixene is combined with codeine.


The risk or severity of adverse effects can be increased when estazolam is combined with Perospirone.


The risk or severity of adverse effects can be increased when prilocaine is combined with protriptyline.


The risk or severity of adverse effects can be increased when Pinaverium is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when moclobemide is combined with Pipamperone.


The risk or severity of adverse effects can be increased when prilocaine is combined with cetirizine.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with betamethasone.


The risk or severity of adverse effects can be increased when pentazocine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when flurazepam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when pentazocine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with nitrazepam.


The risk or severity of adverse effects can be increased when cabergoline is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when pergolide is combined with DALFOPRISTIN.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with oxaprozin.


The risk or severity of adverse effects can be increased when morniflumate is combined with Apremilast.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when oxazepam is combined with clozapine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Agomelatine.


The risk or severity of adverse effects can be increased when dyclonine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when glutethimide is combined with METAXALONE.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with lithium ion.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with estrone.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Butethal.


The risk or severity of adverse effects can be increased when Luliconazole is combined with oxycodone.


The risk or severity of adverse effects can be increased when chloroxine is combined with nifedipine.


The risk or severity of adverse effects can be increased when gabapentin is combined with tetracaine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when propantheline is combined with dicyclomine.


The risk or severity of adverse effects can be increased when propantheline is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when flunarizine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when cilazapril is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when naratriptan is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when methazolamide is combined with Bretylium.


The risk or severity of adverse effects can be increased when Pramocaine is combined with sertraline.


The risk or severity of adverse effects can be increased when pentazocine is combined with nitrazepam.


The risk or severity of adverse effects can be increased when topiramate is combined with trimipramine.


The risk or severity of adverse effects can be increased when naratriptan is combined with risperidone.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Fospropofol.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with nitrazepam.


The risk or severity of adverse effects can be increased when nicotinamide is combined with fluvastatin.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with paramethasone.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with tizanidine.


The risk or severity of adverse effects can be increased when glutethimide is combined with ethosuximide.


The risk or severity of adverse effects can be increased when nicotinamide is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when triazolam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when cerulenin is combined with barnidipine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with enflurane.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with formestane.


The risk or severity of adverse effects can be increased when butabarbital is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Olopatadine.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when codeine is combined with PAMABROM.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with formestane.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when perphenazine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when benzphetamine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with cetirizine.


The risk or severity of adverse effects can be increased when clozapine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when meprobamate is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when captopril is combined with Metipranolol.


The risk or severity of adverse effects can be increased when nicergoline is combined with Fosamprenavir.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when sulindac is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when butenafine is combined with Pregabalin.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Normethadone.


The risk or severity of adverse effects can be increased when Clofarabine is combined with MOXONIDINE.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with 6-Mercaptopurine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when promazine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when dibucaine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Asenapine is combined with brotizolam.


The risk or severity of adverse effects can be increased when pergolide is combined with Sitaxsentan.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with tetracaine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when methylene blue is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Sacubitril is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when amphotericin b is combined with tretinoin.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when methadone is combined with Eplerenone.


The risk or severity of adverse effects can be increased when bumetanide is combined with hydralazine.


The risk or severity of adverse effects can be increased when desipramine is combined with metaproterenol.


The risk or severity of adverse effects can be increased when tubocurarine is combined with pancuronium.


The risk or severity of adverse effects can be increased when felbamate is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Normethadone.


The risk or severity of adverse effects can be increased when tubocurarine is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when tubocurarine is combined with Vecuronium.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with estazolam.


The risk or severity of adverse effects can be increased when nifedipine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when trimetrexate is combined with bepridil.


The risk or severity of adverse effects can be increased when clorazepate is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when terbutaline is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with carisoprodol.


The risk or severity of adverse effects can be increased when butorphanol is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when chloroxine is combined with nimodipine.


The risk or severity of adverse effects can be increased when rapamycin is combined with cilnidipine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Suvorexant is combined with Milnacipran.


The risk or severity of adverse effects can be increased when ethosuximide is combined with duloxetine.


The risk or severity of adverse effects can be increased when selegiline is combined with sevoflurane.


The risk or severity of adverse effects can be increased when ethosuximide is combined with fluoxetine.


The risk or severity of adverse effects can be increased when glyburide is combined with ethanol.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with felodipine.


The risk or severity of adverse effects can be increased when halcinonide is combined with physostigmine.


The risk or severity of adverse effects can be increased when ramipril is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when reserpine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when Salsalate is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when halcinonide is combined with rivastigmine.


The risk or severity of adverse effects can be increased when captopril is combined with salicylamide.


The risk or severity of adverse effects can be increased when reserpine is combined with baclofen.


The risk or severity of adverse effects can be increased when scopolamine is combined with duloxetine.


The risk or severity of adverse effects can be increased when propofol is combined with mecamylamine.


The risk or severity of adverse effects can be increased when propofol is combined with trazodone.


The risk or severity of adverse effects can be increased when thiopental is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when quinapril is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with levodopa.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with topiramate.


The risk or severity of adverse effects can be increased when quinapril is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Tolcapone is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with paramethasone.


The risk or severity of adverse effects can be increased when Halazepam is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when triazolam is combined with clozapine.


The risk or severity of adverse effects can be increased when ILOPROST is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when etodolac is combined with Tixocortol.


The risk or severity of adverse effects can be increased when Halazepam is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when alclofenac is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when propranolol is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when ropinirole is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Metipranolol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with triamcinolone.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when lidocaine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when mecamylamine is combined with pirenzepine.


The risk or severity of adverse effects can be increased when bifonazole is combined with diltiazem.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Salsalate.


The risk or severity of adverse effects can be increased when clonidine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Droxicam.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with nylidrin.


The risk or severity of adverse effects can be increased when pirenzepine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when nefazodone is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when secobarbital is combined with dantrolene.


The risk or severity of adverse effects can be increased when buspirone is combined with scopolamine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with nitrazepam.


The risk or severity of adverse effects can be increased when isoflurane is combined with spironolactone.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when metaraminol is combined with benzphetamine.


The risk or severity of adverse effects can be increased when metaraminol is combined with ritodrine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with barnidipine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Apremilast.


The risk or severity of adverse effects can be increased when morphine is combined with metolazone.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when buspirone is combined with Perospirone.


The risk or severity of adverse effects can be increased when nicergoline is combined with thiopental.


The risk or severity of adverse effects can be increased when Naftifine is combined with ibuprofen.


The risk or severity of adverse effects can be increased when amisulpride is combined with clonidine.


The risk or severity of adverse effects can be increased when propranolol is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when ketamine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when oxycodone is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when ketamine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when diazepam is combined with propoxyphene.


The risk or severity of adverse effects can be increased when diazepam is combined with dyclonine.


The risk or severity of adverse effects can be increased when oxycodone is combined with oxazepam.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with paroxetine.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when ethyl icosapentate is combined with aspirin.


The risk or severity of adverse effects can be increased when Aclidinium is combined with buprenorphine.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with butamben.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with furosemide.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with tizanidine.


The risk or severity of adverse effects can be increased when clemastine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Cariprazine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Nebivolol.


The risk or severity of adverse effects can be increased when barnidipine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when isradipine is combined with minoxidil.


The risk or severity of adverse effects can be increased when venlafaxine is combined with mirtazapine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Ixabepilone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with ketamine.


The risk or severity of adverse effects can be increased when methylphenidate is combined with amantadine.


The risk or severity of adverse effects can be increased when selegiline is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with METAXALONE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with bromazepam.


The risk or severity of adverse effects can be increased when felbamate is combined with clomipramine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with tubocurarine.


The risk or severity of adverse effects can be increased when ketorolac is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Olopatadine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with PAMABROM.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when perphenazine is combined with efavirenz.


The risk or severity of adverse effects can be increased when Arotinolol is combined with fenoldopam.


The risk or severity of adverse effects can be increased when minoxidil is combined with nifedipine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with indapamide.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with budesonide.


The risk or severity of adverse effects can be increased when ondansetron is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when midazolam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when acebutolol is combined with cilazapril.


The risk or severity of adverse effects can be increased when midazolam is combined with thiothixene.


The risk or severity of adverse effects can be increased when cerulenin is combined with flunarizine.


The risk or severity of adverse effects can be increased when midazolam is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with primidone.


The risk or severity of adverse effects can be increased when fluoxetine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when prilocaine is combined with zotepine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with estrone.


The risk or severity of adverse effects can be increased when phentolamine is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when losartan is combined with Apremilast.


The risk or severity of adverse effects can be increased when salicylic acid is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when oxazepam is combined with nalbuphine.


The risk or severity of adverse effects can be increased when thiopental is combined with efavirenz.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when phentolamine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with clidinium.


The risk or severity of adverse effects can be increased when felodipine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when mepivacaine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when perphenazine is combined with gabapentin.


The risk or severity of adverse effects can be increased when meperidine is combined with Torasemide.


The risk or severity of adverse effects can be increased when protriptyline is combined with Sodium phosphate monobasic.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with Clevidipine.


The risk or severity of adverse effects can be increased when ethosuximide is combined with efavirenz.


The risk or severity of adverse effects can be increased when suprofen is combined with flumethasone.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with Milnacipran.


The risk or severity of adverse effects can be increased when halothane is combined with benazepril.


The risk or severity of adverse effects can be increased when halothane is combined with amoxapine.


The risk or severity of adverse effects can be increased when halothane is combined with nortriptyline.


The risk or severity of adverse effects can be increased when diltiazem is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Rotigotine is combined with timolol.


The risk or severity of adverse effects can be increased when dapsone is combined with acetaminophen.


The risk or severity of adverse effects can be increased when triflupromazine is combined with doxepin.


The risk or severity of adverse effects can be increased when carbamazepine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when suprofen is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when phenmetrazine is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when biperiden is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when isradipine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Elbasvir.


The risk or severity of adverse effects can be increased when buprenorphine is combined with Alvimopan.


The risk or severity of adverse effects can be increased when Milnacipran is combined with Pipamperone.


The risk or severity of adverse effects can be increased when diflunisal is combined with Clobetasone.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with meperidine.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when perphenazine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with flunarizine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with salicylic acid.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with nitric oxide.


The risk or severity of adverse effects can be increased when zopiclone is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when tetracaine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Fospropofol.


The risk or severity of adverse effects can be increased when zopiclone is combined with bromazepam.


The risk or severity of adverse effects can be increased when enflurane is combined with citalopram.


The risk or severity of adverse effects can be increased when baclofen is combined with Pizotifen.


The risk or severity of adverse effects can be increased when benzocaine is combined with clemastine.


The risk or severity of adverse effects can be increased when benzocaine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Torasemide is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when cocaine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Artemether is combined with nitrendipine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with brotizolam.


The risk or severity of adverse effects can be increased when Torasemide is combined with gentamicin.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when tolmetin is combined with halcinonide.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with enalapril.


The risk or severity of adverse effects can be increased when tolmetin is combined with difluprednate.


The risk or severity of adverse effects can be increased when Halazepam is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Halazepam is combined with Desloratadine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with promethazine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with clonazepam.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with nadolol.


The risk or severity of adverse effects can be increased when epinastine is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with nimesulide.


The risk or severity of adverse effects can be increased when Fidaxomicin is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when oxazepam is combined with oxymorphone.


The risk or severity of adverse effects can be increased when fusidic acid is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with topiramate.


The risk or severity of adverse effects can be increased when Rotigotine is combined with labetalol.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Lurasidone.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Ticagrelor.


The risk or severity of adverse effects can be increased when Rotigotine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when thiothixene is combined with Retigabine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when Rotigotine is combined with doxazosin.


The risk or severity of adverse effects can be increased when thiopental is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with clotiazepam.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Vildagliptin is combined with benazepril.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with papaverine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with duloxetine.


The risk or severity of adverse effects can be increased when clorazepate is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when doxazosin is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when meperidine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when linezolid is combined with haloperidol.


The risk or severity of adverse effects can be increased when Tolcapone is combined with flunarizine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when tacrolimus is combined with oxaliplatin.


The risk or severity of adverse effects can be increased when linezolid is combined with triflupromazine.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when topiramate is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when ketamine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with baclofen.


The risk or severity of adverse effects can be increased when nicergoline is combined with ranitidine.


The risk or severity of adverse effects can be increased when oxazepam is combined with olanzapine.


The risk or severity of adverse effects can be increased when lidocaine is combined with Perospirone.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when thiothixene is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when temazepam is combined with Pramocaine.


The risk or severity of adverse effects can be increased when cabergoline is combined with nifedipine.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with Mirabegron.


The risk or severity of adverse effects can be increased when thiothixene is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when temazepam is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when clozapine is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when amphotericin b is combined with penbutolol.


The risk or severity of adverse effects can be increased when fosinopril is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with acemetacin.


The risk or severity of adverse effects can be increased when tolmetin is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when lorazepam is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when diclofenac is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when lorazepam is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when thalidomide is combined with enalapril.


The risk or severity of adverse effects can be increased when lisinopril is combined with Bretylium.


The risk or severity of adverse effects can be increased when tubocurarine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when cabergoline is combined with betamethasone.


The risk or severity of adverse effects can be increased when alprazolam is combined with nitrazepam.


The risk or severity of adverse effects can be increased when cabergoline is combined with teniposide.


The risk or severity of adverse effects can be increased when Flupentixol is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when buprenorphine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when cabergoline is combined with lansoprazole.


The risk or severity of adverse effects can be increased when Olsalazine is combined with acetazolamide.


The risk or severity of adverse effects can be increased when valsartan is combined with prazosin.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with ROLITETRACYCLINE.


The risk or severity of adverse effects can be increased when Risedronic acid is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when furazolidone is combined with terbutaline.


The risk or severity of adverse effects can be increased when quazepam is combined with sulpiride.


The risk or severity of adverse effects can be increased when quazepam is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Risedronic acid is combined with fluvastatin.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when terbinafine is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when morphine is combined with Eszopiclone.


The risk or severity of adverse effects can be increased when morphine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with efavirenz.


The risk or severity of adverse effects can be increased when morphine is combined with loxapine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Clobetasone.


The risk or severity of adverse effects can be increased when cabergoline is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when cabergoline is combined with doxorubicin.